Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Brian Alldredge, PharmD

    TitleVice Provost-Academic Affairs
    SchoolUCSF Chancellor/EVC/FAS
    DepartmentVice Provost-Academic Aff
    Address513 Parnassus Ave, Med Sci
    San Francisco CA 94143
    Phone415-514-0421

       Biography 
       Education and Training
      University of California, San FranciscoPharm.D. Pharmacy1984

       Overview 
       Overview
      Brian Alldredge is a clinician-educator-researcher with research and clinical interests in epilepsy, seizure emergencies, pharmacogenomics, and pharmacy education. He serves as Vice Provost-Academic Affairs for the UCSF campus and he holds joint appointments as a professor of clinical pharmacy in the School of Pharmacy and a clinical professor in the Department of Neurology in the School of Medicine.


       ORNG Applications 
       Websites
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Alldredge BK, Kayser SR. In reply. JAMA Intern Med. 2013 Aug 12; 173(15):1473.
        View in: PubMed
      2. De novo mutations in epileptic encephalopathies. Nature. 2013 Sep 12; 501(7466):217-21.
        View in: PubMed
      3. Riviello JJ, Claassen J, LaRoche SM, Sperling MR, Alldredge B, Bleck TP, Glauser T, Shutter L, Treiman DM, Vespa PM, Bell R, Brophy GM. Treatment of status epilepticus: an international survey of experts. Neurocrit Care. 2013 Apr; 18(2):193-200.
        View in: PubMed
      4. Alldredge BK, Kayser SR. Bending the curve toward increased use of generic drugs. JAMA Intern Med. 2013 Feb 11; 173(3):233-4.
        View in: PubMed
      5. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ, Shutter L, Sperling MR, Treiman DM, Vespa PM. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012 Aug; 17(1):3-23.
        View in: PubMed
      6. Auerbach AD, Sehgal NL, Blegen MA, Maselli J, Alldredge BK, Vittinghoff E, Wachter RM. Effects of a multicentre teamwork and communication programme on patient outcomes: results from the Triad for Optimal Patient Safety (TOPS) project. BMJ Qual Saf. 2012 Feb; 21(2):118-26.
        View in: PubMed
      7. Blegen MA, Sehgal NL, Alldredge BK, Gearhart S, Auerbach AA, Wachter RM. Republished paper: Improving safety culture on adult medical units through multidisciplinary teamwork and communication interventions: the TOPS Project. Postgrad Med J. 2010 Dec; 86(1022):729-33.
        View in: PubMed
      8. Blegen MA, Sehgal NL, Alldredge BK, Gearhart S, Auerbach AA, Wachter RM. Improving safety culture on adult medical units through multidisciplinary teamwork and communication interventions: the TOPS Project. Qual Saf Health Care. 2010 Aug; 19(4):346-50.
        View in: PubMed
      9. Blegen MA, Gearhart S, O'Brien R, Sehgal NL, Alldredge BK. AHRQ's hospital survey on patient safety culture: psychometric analyses. J Patient Saf. 2009 Sep; 5(3):139-44.
        View in: PubMed
      10. Kaiboriboon K, Guevara M, Alldredge BK. Understanding herb and dietary supplement use in patients with epilepsy. Epilepsia. 2009 Aug; 50(8):1927-32.
        View in: PubMed
      11. Sehgal NL, Fox M, Vidyarthi AR, Sharpe BA, Gearhart S, Bookwalter T, Barker J, Alldredge BK, Blegen MA, Wachter RM. A multidisciplinary teamwork training program: the Triad for Optimal Patient Safety (TOPS) experience. J Gen Intern Med. 2008 Dec; 23(12):2053-7.
        View in: PubMed
      12. El-Ibiary SY, Cheng C, Alldredge B. Potential roles for pharmacists in pharmacogenetics. J Am Pharm Assoc (2003). 2008 Mar-Apr; 48(2):e21-29; quiz e30-32.
        View in: PubMed
      13. Issa AM, Phillips KA, Van Bebber S, Nidamarthy HG, Lasser KE, Haas JS, Alldredge BK, Wachter RM, Bates DW. Drug withdrawals in the United States: a systematic review of the evidence and analysis of trends. Curr Drug Saf. 2007 Sep; 2(3):177-85.
        View in: PubMed
      14. Alldredge BK, Koda-Kimble MA. Count and be counted: preparing future pharmacists to promote a culture of safety. Am J Pharm Educ. 2006 Aug 15; 70(4):92.
        View in: PubMed
      15. Fenn HH, Sommer BR, Ketter TA, Alldredge B. Safety and tolerability of mood-stabilising anticonvulsants in the elderly. Expert Opin Drug Saf. 2006 May; 5(3):401-16.
        View in: PubMed
      16. Lee KC, Garcia PA, Alldredge BK. Clinical features of status epilepticus in patients with HIV infection. Neurology. 2005 Jul 26; 65(2):314-6.
        View in: PubMed
      17. Phillips KA, Liang SY, Haas JS, Stebbins M, Alldredge BK. Prescription drug dispensing limits and patterns. Manag Care Interface. 2005 Jul; 18(7):41-6.
        View in: PubMed
      18. Lee KC, Finley PR, Alldredge BK. Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings. Expert Opin Drug Saf. 2003 May; 2(3):233-47.
        View in: PubMed
      19. Chen JT, Garcia PA, Alldredge BK. Zonisamide-induced restless legs syndrome. Neurology. 2003 Jan 14; 60(1):147.
        View in: PubMed
      20. Alldredge BK, Venteicher R, Calderwood TS. Stability of diazepam rectal gel in ambulance-like environments. Am J Emerg Med. 2002 Mar; 20(2):88-91.
        View in: PubMed
      21. Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, Gottwald MD, O'Neil N, Neuhaus JM, Segal MR, Lowenstein DH. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001 Aug 30; 345(9):631-7.
        View in: PubMed
      22. Lowenstein DH, Alldredge BK, Allen F, Neuhaus J, Corry M, Gottwald M, O'Neil N, Ulrich S, Isaacs SM, Gelb A. The prehospital treatment of status epilepticus (PHTSE) study: design and methodology. Control Clin Trials. 2001 Jun; 22(3):290-309.
        View in: PubMed
      23. Bourdet SV, Gidal BE, Alldredge BK. Pharmacologic management of epilepsy in the elderly. J Am Pharm Assoc (Wash). 2001 May-Jun; 41(3):421-36.
        View in: PubMed
      24. Gottwald MD, Akers LC, Liu PK, Orsulak PJ, Corry MD, Bacchetti P, Fields SM, Lowenstein DH, Alldredge BK. Prehospital stability of diazepam and lorazepam. Am J Emerg Med. 1999 Jul; 17(4):333-7.
        View in: PubMed
      25. Aweeka FT, Gottwald MD, Gambertoglio JG, Wright TL, Boyer TD, Pollock AS, Eldon MA, Kugler AR, Alldredge BK. Pharmacokinetics of fosphenytoin in patients with hepatic or renal disease. Epilepsia. 1999 Jun; 40(6):777-82.
        View in: PubMed
      26. Alldredge BK, Lowenstein DH. Status epilepticus: new concepts. Curr Opin Neurol. 1999 Apr; 12(2):183-90.
        View in: PubMed
      27. Alldredge BK. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Neurology. 1999; 53(5 Suppl 2):S68-75.
        View in: PubMed
      28. Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med. 1998 Apr 2; 338(14):970-6.
        View in: PubMed
      29. Gottwald MD, Bainbridge JL, Dowling GA, Aminoff MJ, Alldredge BK. New pharmacotherapy for Parkinson's disease. Ann Pharmacother. 1997 Oct; 31(10):1205-17.
        View in: PubMed
      30. Alldredge BK. Drug-induced seizures: controversies in their identification and management. Pharmacotherapy. 1997 Sep-Oct; 17(5):857-60.
        View in: PubMed
      31. Alldredge BK, Wall DB, Ferriero DM. Effect of prehospital treatment on the outcome of status epilepticus in children. Pediatr Neurol. 1995 Apr; 12(3):213-6.
        View in: PubMed
      32. Alldredge BK, Heard SE, Parko K. Is the prescription really for selegiline? Am J Hosp Pharm. 1994 Apr 1; 51(7):930, 932.
        View in: PubMed
      33. Alldredge BK, Knutsen AP, Ferriero D. Antiepileptic drug hypersensitivity syndrome: in vitro and clinical observations. Pediatr Neurol. 1994 Mar; 10(2):169-71.
        View in: PubMed
      34. Garcia PA, Alldredge BK. Drug-induced seizures. Neurol Clin. 1994 Feb; 12(1):85-99.
        View in: PubMed
      35. Alldredge BK, Lowenstein DH. Status epilepticus related to alcohol abuse. Epilepsia. 1993 Nov-Dec; 34(6):1033-7.
        View in: PubMed
      36. Harb GE, Alldredge BK, Coleman R, Jacobson MA. Pharmacoepidemiology of adverse drug reactions in hospitalized patients with human immunodeficiency virus disease. J Acquir Immune Defic Syndr. 1993 Aug; 6(8):919-26.
        View in: PubMed
      37. Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology. 1993 Mar; 43(3 Pt 1):483-8.
        View in: PubMed
      38. Lowenstein DH, Alldredge B. Managing status epilepticus. Lancet. 1990 Dec 8; 336(8728):1451.
        View in: PubMed
      39. Chan J, Alldredge BK, Baskin LS. Perphenazine-induced priapism. DICP. 1990 Mar; 24(3):246-9.
        View in: PubMed
      40. Alldredge BK, Lowenstein DH, Simon RP. Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures. Am J Med. 1989 Dec; 87(6):645-8.
        View in: PubMed
      41. Alldredge BK, Lowenstein DH, Simon RP. Seizures associated with recreational drug abuse. Neurology. 1989 Aug; 39(8):1037-9.
        View in: PubMed
      Brian's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP